UK moves to address dire state of stroke care
This article was originally published in Clinica
There can be no stronger argument for a revolutionary investment in diagnostic imaging in the UK than is shown by the need for a radical improvement in the care of stroke - or do this specialism's needs lie elsewhere? The government, clinicians and pressure groups do not know the answer to this question and the ignorance is resulting in high levels of death and morbidity, which are not even recorded correctly due to widespread delay or failures in diagnosing stroke and transient ischaemic attack (TIA).
You may also be interested in...
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.
At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.